Tamoxifen and oxidative stress: an overlooked connection

被引:24
作者
Ahmed, Nermin S. [1 ]
Samec, Marek [2 ]
Liskova, Alena [2 ]
Kubatka, Peter [3 ]
Saso, Luciano [4 ]
机构
[1] German Univ Cairo, Fac Pharm & Biotechnol, Dept Pharmaceut Chem, Cairo 11835, Egypt
[2] Comenius Univ, Jessenius Fac Med, Dept Obstet & Gynecol, Martin 03601, Slovakia
[3] Comenius Univ, Jessenius Fac Med, Dept Med Biol, Dept Expt Carcinogenesis,Biomed Ctr Martin,Div On, Mala Hora 4, Martin 03601, Slovakia
[4] Sapienza Univ, Dept Physiol & Pharmacol Vittorio Erspamer, Ple Aldo Moro 5, I-00185 Rome, Italy
关键词
Apoptosis; ER; Oxidative stress; Resistance; Tamoxifen; PROTEIN-KINASE-C; BREAST-CANCER CELLS; ESTROGEN-RECEPTOR-ALPHA; ACQUIRED ENDOCRINE RESISTANCE; ANTICANCER DRUG TAMOXIFEN; POSTMENOPAUSAL WOMEN; INDUCED APOPTOSIS; INDUCED HEPATOTOXICITY; CYP2D6; POLYMORPHISMS; MULTIDRUG-RESISTANCE;
D O I
10.1007/s12672-021-00411-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tamoxifen is the gold standard drug for the treatment of breast cancer in pre and post-menopausal women. Its journey from a failing contraceptive to a blockbuster is an example of pharmaceutical innovation challenges. Tamoxifen has a wide range of pharmacological activities; a drug that was initially thought to work via a simple Estrogen receptor (ER) mechanism was proven to mediate its activity through several non-ER mechanisms. Here in we review the previous literature describing ER and non-ER targets of tamoxifen, we highlighted the overlooked connection between tamoxifen, tamoxifen apoptotic effects and oxidative stress.
引用
收藏
页数:15
相关论文
共 114 条
[1]   Tamoxifen and the PI3K Inhibitor: LY294002 Synergistically Induce Apoptosis and Cell Cycle Arrest in Breast Cancer MCF-7 Cells [J].
Abdallah, Mohamed E. ;
El-Readi, Mahmoud Zaki ;
Althubiti, Mohammad Ahmad ;
Almaimani, Riyad Adnan ;
Ismail, Amar Mohamed ;
Idris, Shakir ;
Refaat, Bassem ;
Almalki, Waleed Hassan ;
Babakr, Abdullatif Taha ;
Mukhtar, Mohammed H. ;
Abdalla, Ashraf N. ;
Idris, Omer Fadul .
MOLECULES, 2020, 25 (15)
[2]   Protective effect of lycopene against tamoxifen-induced hepatotoxicity in albino rats [J].
Adikwu, Elias ;
Ebinyo, Nelson Clemente ;
Benalayefa, Ozeke .
BIOMEDICAL AND BIOTECHNOLOGY RESEARCH JOURNAL, 2020, 4 (01) :69-75
[3]   Synthesis of novel flexible tamoxifen analogues to overcome CYP2D6 polymorphism and their biological evaluation on MCF-7 cell line [J].
Ahmed, Nermin S. ;
Wober, Jannette .
DRUG DEVELOPMENT RESEARCH, 2020, 81 (04) :444-455
[4]   Design and synthesis of novel tamoxifen analogues that avoid CYP2D6 metabolism [J].
Ahmed, Nermin S. ;
Elghazawy, Nehal H. ;
ElHady, Ahmed K. ;
Engel, Matthias ;
Hartmann, Rolf W. ;
Abadi, Ashraf H. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 112 :171-179
[5]   Phospholipase C-protein kinase C mediated phospholipase D activation pathway is involved in tamoxifen induced apoptosis [J].
Ahn, SJ ;
Yoon, MS ;
Hyuk, S ;
Han, W ;
Yoon, YD ;
Han, JS ;
Noh, DY .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 89 (03) :520-528
[6]   ESTROGEN ACTION VIA THE CAMP SIGNALING PATHWAY - STIMULATION OF ADENYLATE-CYCLASE AND CAMP-REGULATED GENE-TRANSCRIPTION [J].
ARONICA, SM ;
KRAUS, WL ;
KATZENELLENBOGEN, BS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (18) :8517-8521
[7]   Oxidative stress contributes to the tamoxifen-induced killing of breast cancer cells: implications for tamoxifen therapy and resistance [J].
Bekele, Raie T. ;
Venkatraman, Ganesh ;
Liu, Rong-Zong ;
Tang, Xiaoyun ;
Mi, Si ;
Benesch, Matthew G. K. ;
Mackey, John R. ;
Godbout, Roseline ;
Curtis, Jonathan M. ;
McMullen, Todd P. W. ;
Brindley, David N. .
SCIENTIFIC REPORTS, 2016, 6
[8]   Estradiol signaling via sequestrable surface receptors [J].
Benten, WPM ;
Stephan, C ;
Lieberherr, M ;
Wunderlich, F .
ENDOCRINOLOGY, 2001, 142 (04) :1669-1677
[9]   CYP2D6 Polymorphisms and the impact on tamoxifen therapy [J].
Beverage, Jacob N. ;
Sissung, Tristan M. ;
Sion, Amy M. ;
Danesi, Romano ;
Figg, William D. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (09) :2224-2231
[10]   A new marker of tamoxifen resistance of estrogen receptor-positive breast cancer [J].
Bogush, E. A. ;
Ravcheeva, A. B. ;
Bogush, T. A. ;
Zabotina, T. N. ;
Kadagidze, Z. G. ;
Davydov, M. I. .
DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2007, 413 (01) :83-87